Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6286)
All Articles published online
|
Publishing Process of This Article
|
May 10, 2014 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Larson EW, Peterson HE, Lamoreaux WT, MacKay AR, Fairbanks RK, Call JA, Carlson JD, Ling BC, Demakas JJ, Cooke BS, Lee CM. Clinical outcomes following salvage Gamma Knife radiosurgery for recurrent glioblastoma. World J Clin Oncol 2014; 5(2): 142-148 [PMID: 24829861 DOI: 10.5306/wjco.v5.i2.142] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v5/i2/142.htm |
| Number | Citing Articles |
| 1 |
Yong-Pyo Lee, Hyun Ae Jung, Min-Sang Lee, Jung Won Choi, Doo-Sik Kong, Ho Jun Seol, Do-Hyun Nam, Jung-Il Lee, Se-Hoon Lee. Bevacizumab plus irinotecan with or without gamma knife radiosurgery after failure of concurrent chemo-radiotherapy for high-grade glioma. Journal of Neuro-Oncology 2022; 156(3): 541 doi: 10.1007/s11060-021-03930-4
|
| 2 |
Jeremy C. Ganz. Recent Advances and Controversies in Gamma Knife Neurosurgery. Progress in Brain Research 2022; 268: 259 doi: 10.1016/bs.pbr.2021.10.035
|
| 3 |
Ethan Berney, Nirupama Sabnis, Marlyn Panchoo, Sangram Raut, Rob Dickerman, Andras G. Lacko. The SR-B1 Receptor as a Potential Target for Treating Glioblastoma. Journal of Oncology 2019; 2019: 1 doi: 10.1155/2019/1805841
|
| 4 |
S. Lévy, S. Chapet, N. Scher, K. Debbi, A. Ruffier, G. Bernadou, Y. Pointreau, G. Calais. Reirradiation of gliomas under stereotactic conditions: Prognostic factors for survival without relapse or side effects, a retrospective study at Tours regional university hospital (France). Cancer/Radiothérapie 2017; 21(8): 759 doi: 10.1016/j.canrad.2017.05.006
|
| 5 |
David Bergman, Ankit Modh, Lonni Schultz, James Snyder, Tom Mikkelsen, Mira Shah, Samuel Ryu, M. Salim Siddiqui, Tobias Walbert. Randomized prospective trial of fractionated stereotactic radiosurgery with chemotherapy versus chemotherapy alone for bevacizumab-resistant high-grade glioma. Journal of Neuro-Oncology 2020; 148(2): 353 doi: 10.1007/s11060-020-03526-4
|
| 6 |
Minjie Fu, Zhirui Zhou, Xiao Huang, Zhenchao Chen, Licheng Zhang, Jinsen Zhang, Wei Hua, Ying Mao. Use of Bevacizumab in recurrent glioblastoma: a scoping review and evidence map. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11043-6
|
| 7 |
Yadi Wang, Hongwei Wang, Zhanbiao He, Yang Gao, Jianbo Li, Guorong Zhang, Jun Yin. A preliminary study on the application of DTI in the treatment of brain tumors in motor function areas with gamma knife. Clinical Neurology and Neurosurgery 2020; 197: 106169 doi: 10.1016/j.clineuro.2020.106169
|
| 8 |
Fidan Seker-Polat, Nareg Pinarbasi Degirmenci, Ihsan Solaroglu, Tugba Bagci-Onder. Tumor Cell Infiltration into the Brain in Glioblastoma: From Mechanisms to Clinical Perspectives. Cancers 2022; 14(2): 443 doi: 10.3390/cancers14020443
|
| 9 |
Jeff F. Zhang, Bernard Okai, Austin Iovoli, Victor Goulenko, Kristopher Attwood, Jaims Lim, Ryan M. Hess, Ajay P. Abad, Dheerendra Prasad, Robert A. Fenstermaker. Bevacizumab and gamma knife radiosurgery for first-recurrence glioblastoma. Journal of Neuro-Oncology 2024; 166(1): 89 doi: 10.1007/s11060-023-04524-y
|
| 10 |
S. Arab, F. Hasannejad. An overview of current therapeutic strategies for glioblastoma and the role of CD73 as an alternative curative approach. Clinical and Translational Oncology 2021; 24(5): 742 doi: 10.1007/s12094-021-02732-4
|
| 11 |
Xin He, Yuduo Guo, Chunjiang Yu, Hongwei Zhang, Shengdian Wang. Epithelial-mesenchymal transition is the main way in which glioma-associated microglia/macrophages promote glioma progression. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1097880
|
| 12 |
Bao Wang, Peng Zhao, Yi Zhang, Mingxu Ge, Chuanjin Lan, Chuanting Li, Qi Pang, Shangchen Xu, Yingchao Liu. Quantitative dynamic susceptibility contrast perfusion-weighted imaging-guided customized gamma knife re-irradiation of recurrent high-grade gliomas. Journal of Neuro-Oncology 2018; 139(1): 185 doi: 10.1007/s11060-018-2859-8
|
| 13 |
Stanley S. Stylli. Novel Treatment Strategies for Glioblastoma. Cancers 2020; 12(10): 2883 doi: 10.3390/cancers12102883
|
| 14 |
Saint-Aaron L. Morris, Ping Zhu, Mayank Rao, Magda Martir, Jay J. Zhu, Sigmund Hsu, Leomar Y. Ballester, Arthur L. Day, Nitin Tandon, Dong H. Kim, Scott Shepard, Angel Blanco, Yoshua Esquenazi. Gamma Knife Stereotactic Radiosurgery in Combination with Bevacizumab for Recurrent Glioblastoma. World Neurosurgery 2019; 127: e523 doi: 10.1016/j.wneu.2019.03.193
|
| 15 |
Carl Fisher, Girgis Obaid, Carolyn Niu, Warren Foltz, Alyssa Goldstein, Tayyaba Hasan, Lothar Lilge. Liposomal Lapatinib in Combination with Low-Dose Photodynamic Therapy for the Treatment of Glioma. Journal of Clinical Medicine 2019; 8(12): 2214 doi: 10.3390/jcm8122214
|
| 16 |
Liu Zhenjiang, Martin Rao, Xiaohua Luo, Davide Valentini, Anna von Landenberg, Qingda Meng, Georges Sinclair, Nina Hoffmann, Julia Karbach, Hans-Michael Altmannsberger, Elke Jäger, Inti Harvey Peredo, Ernest Dodoo, Markus Maeurer. Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme. EBioMedicine 2018; 33: 49 doi: 10.1016/j.ebiom.2018.06.014
|
| 17 |
Carole Grasso, Marie-Sophie Fabre, Sarah V. Collis, M. Leticia Castro, Cameron S. Field, Nanette Schleich, Melanie J. McConnell, Patries M. Herst. Pharmacological Doses of Daily Ascorbate Protect Tumors from Radiation Damage after a Single Dose of Radiation in an Intracranial Mouse Glioma Model. Frontiers in Oncology 2014; 4 doi: 10.3389/fonc.2014.00356
|
| 18 |
Mayra Paolillo, Cinzia Boselli, Sergio Schinelli. Glioblastoma under Siege: An Overview of Current Therapeutic Strategies. Brain Sciences 2018; 8(1): 15 doi: 10.3390/brainsci8010015
|
| 19 |
Zhenjiang Liu, Martin Rao, Thomas Poiret, Silvia Nava, Qingda Meng, Anna von Landenberg, Jiri Bartek, Shanshan Xie, Georges Sinclair, Inti Peredo, Ernest Dodoo, Markus Maeurer. Mesothelin as a novel biomarker and immunotherapeutic target in human glioblastoma. Oncotarget 2017; 8(46): 80208 doi: 10.18632/oncotarget.20303
|
| 20 |
Byung Sup Kim, Doo-Sik Kong, Ho Jun Seol, Do-Hyun Nam, Jung-Il Lee. MGMT promoter methylation status as a prognostic factor for the outcome of gamma knife radiosurgery for recurrent glioblastoma. Journal of Neuro-Oncology 2017; 133(3): 615 doi: 10.1007/s11060-017-2478-9
|
| 21 |
Marcela Tavares Luiz, Leonardo Delello Di Filippo, Larissa Bueno Tofani, Jennifer Thayanne Cavalcante de Araújo, Jessyca Aparecida Paes Dutra, Juliana Maldonado Marchetti, Marlus Chorilli. Highlights in targeted nanoparticles as a delivery strategy for glioma treatment. International Journal of Pharmaceutics 2021; 604: 120758 doi: 10.1016/j.ijpharm.2021.120758
|
| 22 |
Konstantinos N. Fountas, Eftychia Z. Kapsalaki. Epilepsy Surgery and Intrinsic Brain Tumor Surgery. 2019; : 281 doi: 10.1007/978-3-319-95918-4_26
|
| 23 |
Yona Kim, Frederick S. Varn, Sung-Hye Park, Byung Woo Yoon, Hye Ran Park, Charles Lee, Roel G. W. Verhaak, Sun Ha Paek. Perspective of mesenchymal transformation in glioblastoma. Acta Neuropathologica Communications 2021; 9(1) doi: 10.1186/s40478-021-01151-4
|
| 24 |
Ying Sun, Peiru Liu, Zixi Wang, Haibo Zhang, Ying Xu, Shenghui Hu, Ying Yan. Efficacy and indications of gamma knife radiosurgery for recurrent low-and high-grade glioma. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-023-11772-8
|
| 25 |
Kewal K. Jain. A Critical Overview of Targeted Therapies for Glioblastoma. Frontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00419
|
| 26 |
Vladimir N. Ivanov, Jinhua Wu, Tony J.C. Wang, Tom K. Hei. Inhibition of ATM kinase upregulates levels of cell death induced by cannabidiol and γ-irradiation in human glioblastoma cells. Oncotarget 2019; 10(8): 825 doi: 10.18632/oncotarget.26582
|
| 27 |
Samman Shahpar, Priya V. Mhatre, Mark E. Huang. Update on Brain Tumors: New Developments in Neuro‐oncologic Diagnosis and Treatment, and Impact on Rehabilitation Strategies. PM&R 2016; 8(7): 678 doi: 10.1016/j.pmrj.2015.10.012
|
| 28 |
Antonella Castellano, Michele Bailo, Francesco Cicone, Luciano Carideo, Natale Quartuccio, Pietro Mortini, Andrea Falini, Giuseppe Lucio Cascini, Giuseppe Minniti. Advanced Imaging Techniques for Radiotherapy Planning of Gliomas. Cancers 2021; 13(5): 1063 doi: 10.3390/cancers13051063
|
| 29 |
ShiZhen Zhou, Jun Xu, YuFang Zhu. Phospholipid scramblase 1 acts through the IL-6/JAK/STAT3 pathway to promote the malignant progression of glioma. Archives of Biochemistry and Biophysics 2024; : 110002 doi: 10.1016/j.abb.2024.110002
|
| 30 |
İlknur Alsan Çetin. Atlas of Clinical Cases on Brain Tumor Imaging. 2020; : 105 doi: 10.1007/978-3-030-23273-3_9
|
| 31 |
Christopher Dardis, Lynn Ashby, William Shapiro, Nader Sanai. Biopsy vs. extensive resection for first recurrence of glioblastoma: is a prospective clinical trial warranted?. BMC Research Notes 2015; 8(1) doi: 10.1186/s13104-015-1386-3
|
| 32 |
Jason Sanders, Håkan Nordström, Jason Sheehan, David Schlesinger. Gamma Knife radiosurgery: Scenarios and support for re-irradiation. Physica Medica 2019; 68: 75 doi: 10.1016/j.ejmp.2019.11.001
|
| 33 |
Luis Moreno Sánchez. Glioblastoma: Multidisciplinary treatment approaches. Applied Radiation Oncology 2016; : 17 doi: 10.37549/ARO1090
|